Polynovo (ASX:PNV) Pre-Tax Income : A$0.01 Mil (TTM As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Polynovo Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Polynovo's pretax income for the six months ended in Dec. 2023 was A$1.09 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01 Mil. Polynovo's pretax margin was 2.31%.

During the past 13 years, Polynovo's highest Pretax Margin was 0.01%. The lowest was -47133.33%. And the median was -61.57%.

Polynovo Pre-Tax Income Historical Data

The historical data trend for Polynovo's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo Pre-Tax Income Chart

Polynovo Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Pre-Tax Income

Get a 7-Day Free Trial

-3.19

-4.13

-4.55

-1.15

-4.93

Polynovo Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															1.69	-2.84	-3.86	-1.08	1.09

Competitive Comparison of Polynovo's Pre-Tax Income

For the Medical Devices subindustry, Polynovo's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polynovo's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polynovo's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Polynovo's Pre-Tax Income falls into.

Polynovo Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Polynovo's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-6.185	+	1.096	+	-0.186	+	0.87	+	-0.528
	=	-4.93

Polynovo's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.165	+	0.758	+	-0.055	+	0.858	+	-0.309
	=	1.09

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.01 Mil.

Polynovo (ASX:PNV) Pre-Tax Income Explanation

Polynovo's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	1.087	/	47.149
	=	2.31%

During the past 13 years, Polynovo's highest Pretax Margin was 0.01%. The lowest was -47133.33%. And the median was -61.57%.

Polynovo Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Polynovo's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Polynovo (ASX:PNV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (ASX:PNV) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

CALZF:USA MFJ:Germany

Address

320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207

Website

https://www.polynovo.com

Polynovo earns most of its revenue from U.S. sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

Polynovo (ASX:PNV) Headlines

No Headlines